The Biden Administration Drops Its Foolish Resistance to Drug-Price Transparency
Americans finally have some good news on health care. After years of skyrocketing costs, lower prescription drug prices are coming — despite President Biden’s efforts to force Americans to keep paying more.
That’s a victory our organization won last week in federal court. Earlier this year, we sued the Biden administration for its refusal to implement price transparency for prescription drugs. In 2020, the Trump administration finalized a regulation requiring group health plans and many health-insurance issuers to disclose the price of prescription drugs to consumers.